Clinicians' ability to diagnose dementia with Lewy bodies is not affected by β-amyloid load
To investigate whether an increasing load of β-amyloid and/or neuritic plaques influences the phenotype, and thus the clinical diagnostic accuracy, of dementia with Lewy bodies (DLB). A series of 64 subjects with autopsy-proven DLB was studied. Last diagnosis before death was used to determine the clinical diagnostic accuracy of DLB in relation to Lewy body distribution and extent of Alzheimer β-amyloid and/or neuritic pathology. DLB pathologic diagnosis was made according to consensus criteria, using α-synuclein immunostaining for Lewy body identification. β-Amyloid immunostaining was used for quantifying β-amyloid deposits. The Consortium to Establish a Registry for Alzheimer's Disease criteria and Braak stage were applied for semiquantitative grading of neuritic plaque and neurofibrillary tangle pathology. Overall clinical diagnostic accuracy for the entire DLB cohort was high (80%), reflecting the high prevalence of core clinical features (fluctuations [81%], parkinsonism [77%], visual hallucinations [70%]). Lower frequencies of core clinical features of DLB, resulting in lower accuracy of its clinical diagnosis, were associated with decreasing Lewy body distribution (p < 0.0001) and with increasing neuritic plaque pathology (p = 0.035), but not with the number of β-amyloid plaque deposits. The likelihood of occurrence of the DLB clinical syndrome is positively related to the extent of Lewy body pathology and negatively related to the severity of Alzheimer neuritic pathology, while β-amyloid load has no effect..
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2015 |
|---|---|
| Erschienen: |
2015 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:84 |
|---|---|
| Enthalten in: |
Neurology - 84(2015), 5, Seite 496-499 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Tiraboschi, Pietro [VerfasserIn] |
|---|
| Links: |
|---|
| BKL: | |
|---|---|
| Themen: |
Amyloid beta-Peptides - analysis |
| RVK: |
|---|
| doi: |
10.1212/WNL.0000000000001204 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC1962459225 |
|---|
| LEADER | 01000caa a2200265 4500 | ||
|---|---|---|---|
| 001 | OLC1962459225 | ||
| 003 | DE-627 | ||
| 005 | 20230511081710.0 | ||
| 007 | tu | ||
| 008 | 160206s2015 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1212/WNL.0000000000001204 |2 doi | |
| 028 | 5 | 2 | |a PQ20160617 |
| 035 | |a (DE-627)OLC1962459225 | ||
| 035 | |a (DE-599)GBVOLC1962459225 | ||
| 035 | |a (PRQ)p1384-8985667e42a7a680e2013c464c47ad693c0f6bc32d34c06bd24bb3eb7f4ef9570 | ||
| 035 | |a (KEY)0070612420150000084000500496cliniciansabilitytodiagnosedementiawithlewybodiesi | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q DNB |
| 084 | |a XA 10000 |q AVZ |2 rvk | ||
| 084 | |a 44.90 |2 bkl | ||
| 100 | 1 | |a Tiraboschi, Pietro |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Clinicians' ability to diagnose dementia with Lewy bodies is not affected by β-amyloid load |
| 264 | 1 | |c 2015 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 520 | |a To investigate whether an increasing load of β-amyloid and/or neuritic plaques influences the phenotype, and thus the clinical diagnostic accuracy, of dementia with Lewy bodies (DLB). A series of 64 subjects with autopsy-proven DLB was studied. Last diagnosis before death was used to determine the clinical diagnostic accuracy of DLB in relation to Lewy body distribution and extent of Alzheimer β-amyloid and/or neuritic pathology. DLB pathologic diagnosis was made according to consensus criteria, using α-synuclein immunostaining for Lewy body identification. β-Amyloid immunostaining was used for quantifying β-amyloid deposits. The Consortium to Establish a Registry for Alzheimer's Disease criteria and Braak stage were applied for semiquantitative grading of neuritic plaque and neurofibrillary tangle pathology. Overall clinical diagnostic accuracy for the entire DLB cohort was high (80%), reflecting the high prevalence of core clinical features (fluctuations [81%], parkinsonism [77%], visual hallucinations [70%]). Lower frequencies of core clinical features of DLB, resulting in lower accuracy of its clinical diagnosis, were associated with decreasing Lewy body distribution (p < 0.0001) and with increasing neuritic plaque pathology (p = 0.035), but not with the number of β-amyloid plaque deposits. The likelihood of occurrence of the DLB clinical syndrome is positively related to the extent of Lewy body pathology and negatively related to the severity of Alzheimer neuritic pathology, while β-amyloid load has no effect. | ||
| 540 | |a Nutzungsrecht: © 2014 American Academy of Neurology. | ||
| 540 | |a © 2014 American Academy of Neurology 2014 American Academy of Neurology | ||
| 650 | 4 | |a Amyloid beta-Peptides - analysis | |
| 650 | 4 | |a Plaque, Amyloid - diagnosis | |
| 650 | 4 | |a Plaque, Amyloid - epidemiology | |
| 650 | 4 | |a Lewy Body Disease - diagnosis | |
| 650 | 4 | |a Lewy Body Disease - epidemiology | |
| 700 | 1 | |a Attems, Johannes |4 oth | |
| 700 | 1 | |a Thomas, Alan |4 oth | |
| 700 | 1 | |a Brown, Andrew |4 oth | |
| 700 | 1 | |a Jaros, Evelyn |4 oth | |
| 700 | 1 | |a Lett, Debbie J |4 oth | |
| 700 | 1 | |a Ossola, Maria |4 oth | |
| 700 | 1 | |a Perry, Robert H |4 oth | |
| 700 | 1 | |a Ramsay, Lynne |4 oth | |
| 700 | 1 | |a Walker, Lauren |4 oth | |
| 700 | 1 | |a McKeith, Ian G |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Neurology |d Hagerstown, Md. : Lippincott Williams & Wilkins, 1951 |g 84(2015), 5, Seite 496-499 |w (DE-627)129495174 |w (DE-600)207147-2 |w (DE-576)014893118 |x 0028-3878 |7 nnns |
| 773 | 1 | 8 | |g volume:84 |g year:2015 |g number:5 |g pages:496-499 |
| 856 | 4 | 1 | |u http://dx.doi.org/10.1212/WNL.0000000000001204 |3 Volltext |
| 856 | 4 | 2 | |u http://www.ncbi.nlm.nih.gov/pubmed/25552579 |
| 856 | 4 | 2 | |u http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4336072&tool=pmcentrez&rendertype=abstract |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a GBV_ILN_22 | ||
| 912 | |a GBV_ILN_40 | ||
| 912 | |a GBV_ILN_55 | ||
| 912 | |a GBV_ILN_2002 | ||
| 912 | |a GBV_ILN_2018 | ||
| 912 | |a GBV_ILN_2410 | ||
| 912 | |a GBV_ILN_2412 | ||
| 912 | |a GBV_ILN_4012 | ||
| 912 | |a GBV_ILN_4219 | ||
| 936 | r | v | |a XA 10000 |
| 936 | b | k | |a 44.90 |q AVZ |
| 951 | |a AR | ||
| 952 | |d 84 |j 2015 |e 5 |h 496-499 | ||